Authors:
SLOAND JA
SHELLY MA
ERENSTONE AL
SCHIFF MJ
TALLEY TE
DHAKAL MP
Citation: Ja. Sloand et al., SAFETY AND EFFICACY OF TOTAL-DOSE IRON DEXTRAN ADMINISTRATION IN PATIENTS ON HOME RENAL REPLACEMENT THERAPIES, Peritoneal dialysis international, 18(5), 1998, pp. 522-527
Citation: Ja. Sloand et Em. Sloand, STUDIES ON PLATELET MEMBRANE-GLYCOPROTEINS AND PLATELET-FUNCTION DURING HEMODIALYSIS, Journal of the American Society of Nephrology, 8(5), 1997, pp. 799-803
Citation: M. Dhakal et al., PREVALENCE OF HYPERTENSION (HTN) AND ADEQUACY OF BLOOD-PRESSURE (BP) CONTROL IN HEMODIALYSIS (HD) PATIENTS (PTS) IN THE 90S, Journal of the American Society of Nephrology, 7(9), 1996, pp. 982-982
Citation: Ja. Sloand et Mj. Schiff, BENEFICIAL EFFECT OF LOW-DOSE TRANSDERMAL ESTROGEN ON BLEEDING-TIME AND CLINICAL BLEEDING IN UREMIA, American journal of kidney diseases, 26(1), 1995, pp. 22-26
Citation: Ja. Sloand et al., INFLUENCE OF C1Q ON THE INTERACTION OF MODEL IMMUNE-COMPLEXES WITH HUMAN PLATELETS, Clinical immunology and immunopathology, 76(2), 1995, pp. 127-134
Citation: Rd. Monk et al., RESTLESS LEGS SYNDROME (RLS) IN PATIENTS WITH END-STAGE RENAL-DISEASE(ESRD) - A CASE-CONTROLLED STUDY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 338-338
Citation: Ja. Sloand et Mj. Schiff, BENEFICIAL EFFECT OF LOW-DOSE TRANSDERMAL ESTROGEN ON BLEEDING-TIME (BT) AND CLINICAL BLEEDING IN UREMIA, Journal of the American Society of Nephrology, 5(3), 1994, pp. 340-340
Authors:
ROTH D
SMITH RD
SCHULMAN G
STEINMAN TI
HATCH FE
RUDNICK MR
SLOAND JA
FREEDMAN BI
WILLIAMS WW
SHADUR CA
BENZ RL
TEEHAN BP
REVICKI DA
SAROKHAN BJ
ABELS RI
Citation: D. Roth et al., EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL-FUNCTION IN CHRONIC-RENAL-FAILURE PREDIALYSIS PATIENTS, American journal of kidney diseases, 24(5), 1994, pp. 777-784